Erratum to: Fluorescence spectroscopy as a potential metabonomic tool for early detection of colorectal cancer(Metabolomics, 10.1007/s11306-011-0310-7);Fluorescence spectroscopy as a potential metabonomic tool for early detection of colorectal cancer

Metabolomics

Volumn 8, Issue , 2012, Pages 111-121

  Lawaetz, Anders Juul ^a   Bro, Rasmus ^a   Kamstrup Nielsen, Maja ^a   Christensen, Ib Jarle ^b   Jørgensen, Lars N ^c   Nielsen, Hans J ^d  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b FINSEN LABORATORY   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Chemometrics; Colorectal cancer; Fluorescence spectroscopy; Metabonomics; PARAFAC

Indexed keywords

FLUOROCHROME; PORPHYRIN; TRYPTOPHAN; TYROSINE;

AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CALIBRATION; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CASE CONTROL STUDY; CHEMOMETRICS; COLORECTAL CANCER; CONTROLLED STUDY; DATA ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; EARLY DIAGNOSIS; EXCITATION EMISSION MATRIX MEASUREMENT; FACTORIAL ANALYSIS; FLUORESCENCE SPECTROSCOPY; HUMAN; MAJOR CLINICAL STUDY; MEASUREMENT; METABOLOMICS; PARALLEL FACTOR ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

EID: 84860426821     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-011-0321-4     Document Type: Erratum

References (36)

1. Abugo, O. O., Nair, R., & Lakowicz, J. R. (2000). Fluorescence properties of rhodamine 800 in whole blood and plasma. Analytical Biochemistry, 279, 142-150.
2. Andersen, C. M., & Bro, R. (2003). Practical aspects of PARAFAC modeling of fluorescence excitation-emission data 1. Journal of Chemometrics, 17, 200-215.
3. Bro, R. (1997). PARAFAC. Tutorial and applications 1. Chemometrics and Intelligent Laboratory Systems, 38, 149-171.
4. DeRose, P. C., & Resch-Genger, U. (2010). Recommendations for fluorescence instrument qualification: The new ASTM standard guide. Analytical Chemistry, 82, 2129-2133.
5. Flamini, E., Mercatali, L., Nanni, O., Calistri, D., Nunziatini, R., Zoli, W., et al. (2006). Free DNA and carcinoembryonic antigen serum levels: An important combination for diagnosis of colorectal cancer. Clinical Cancer Research, 12, 6985-6988.
6. Hamdan, M. H. (2007). Cancer biomarkers. Hoboken: John Wiley and sons.
7. Harshman, R. A., & DeSarbo, W. S. (1984). An application of PARAFAC to a small sample problem, demonstrating preprocessing, orthogonality constraints, and split-half diagnostic techniques. In H. G. Law, et al. (Eds.), Research methods for multimode data analysis (pp. 602-642). New York: Praeger.
8. Hubmann, M. R., Leiner, M. J. P., & Schaur, R. J. (1990). Ultraviolet fluorescence of human sera. 1. Sources of characteristic differences in the ultraviolet fluorescence-spectra of sera from normal and cancer-bearing humans 1. Clinical Chemistry, 36, 1880-1883.
9. Jackson, J. E. (1991). Operations with group data. Hoboken: John Wiley & Sons, Inc.
10. Jenkinson, F., & Steele, R. J. C. (2010). Colorectal cancer screening-methodology. Surgeon-Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland, 8, 164-171.
11. Kalaivani, R., Masilamani, V., Sivaji, K., Elangovan, M., Selvaraj, V., Balamurugan, S. G., et al. (2008). Fluorescence spectra of blood components for breast cancer diagnosis. Photomedicine and Laser Surgery, 26, 251-256.
12. Lakowicz, J. R. (2006). Principles of Fluorescence Spectroscopy. New York: Springer.
13. Lawaetz, A. J., & Stedmon, C. A. (2009). Fluorescence intensity calibration using the Raman scatter peak of water. Applied Spectroscopy, 63, 936-940.
14. Leiner, M. J., Schaur, R. J., Desoye, G., & Wolfbeis, O. S. (1986). Fluorescence topography in biology. III: Characteristic deviations of tryptophan fluorescence in sera of patients with gynecological tumors. Clinical Chemistry, 32, 1974-1978.
15. Leiner, M., Schaur, R. J., Wolfbeis, O. S., & Tillian, H. M. (1983). Fluorescence topography in biology. 2. Visible fluorescence topograms of rat sera and cluster-analysis of fluorescence parameters of sera of Yoshida ascites hepatoma-bearing rats. IRCS Medical Science-Biochemistry, 11, 841-842.
16. Lomholt, A. F., Hoyer-Hansen, G., Nielsen, H. J., & Christensen, I. J. (2009). Intact and cleaved forms of the urokinase receptor enhance discrimination of cancer from non-malignant conditions in patients presenting with symptoms related to colorectal cancer. British Journal of Cancer, 101, 992-997.
17. Madhuri, S., Aruna, P., Summiya Bibi, M. I., Gowri, V. S., Koteeswaran, D., Schaur, R. J., et al. (1997). Ultraviolet fluorescence spectroscopy of blood plasma in the discrimination of cancer from normal. Proceedings of SPIE, 2982, 41-45.
18. Madhuri, S., Suchitra, S., Aruna, P., Srinivasan, T. G., & Ganesan, S. (1999). Native fluorescence characteristics of blood plasma of normal and liver diseased subjects. Medical Science Research, 27, 635-639.
19. Madhuri, S., Vengadesan, N., Aruna, P., Koteeswaran, D., Venkatesan, P., & Ganesan, S. (2003). Native fluorescence spectroscopy of blood plasma in the characterization of oral malignancy. Photochemistry and Photobiology, 78, 197-204.
20. Masilamani, V., Al-Zhrani, K., Al-Salhi, M., Al-Diab, A., & Al-Ageily, M. (2004). Cancer diagnosis by autofluorescence of blood components. Journal of Luminescence, 109, 143-154.
21. McKnight, D. M., Boyer, E. W., Westerhoff, P. K., Doran, P. T., Kulbe, T., & Andersen, D. T. (2001). Spectrofluorometric characterization of dissolved organic matter for indication of precursor organic material and aromaticity. Limnology and Oceanography, 46, 38-48.
22. Nielsen, H. J., Brunner, N., Frederiksen, C., Lomholt, A. F., King, D., Jorgensen, L. N., et al. (2008). Plasma tissue inhibitor of metalloproteinases-1 (TIMP-1): a novel biological marker in the detection of primary colorectal cancer. Protocol outlines of the Danish-Australian endoscopy study group on colorectal cancer detection. Scandinavian Journal of Gastroenterology, 43, 242-248.
23. Nordström, A., & Lewensohn, R. (2010). Metabolomics: Moving to the Clinic. Journal of Neuroimmune Pharmacology, 5, 4-17.
24. Nørgaard, L., Saudland, A., Wagner, J., Nielsen, J. P., Munck, L., & Engelsen, S. B. (2000). Interval partial least-squares regression (iPLS): A comparative chemometric study with an example from near-infrared spectroscopy. Applied Spectroscopy, 54, 413-419.
25. Nørgaard, L., Soletormos, G., Harrit, N., Albrechtsen, M., Olsen, O., Nielsen, D., et al. (2007). Fluorescence spectroscopy and chemometrics for classification of breast cancer samples-a feasibility study using extended canonical variates analysis. Journal of Chemometrics, 21, 451-458.
26. Ragazzi, E., Pucciarelli, S., Seraglia, R., Molin, L., Agostini, M., Lise, M., et al. (2006). Multivariate analysis approach to the plasma protein profile of patients with advanced colorectal cancer. Journal of Mass Spectrometry, 41, 1546-1553.
27. The Danish Cancer Society. (2010). http://www. cancer. dk.
28. The Danish National Board of Health. (2010). National screening for tyk- og endetarmskræft. The Danish National Board of Health, 1.
29. Uppal, A., Ghosh, N., Datta, A., & Gupta, P. K. (2005). Fluorimetric estimation of the concentration of NADH from human blood samples 1. Biotechnology and Applied Biochemistry, 41, 43-47.
30. Vivian, J. T., & Callis, P. R. (2001). Mechanisms of tryptophan fluorescence shifts in proteins. Biophysical Journal, 80, 2093-2109.
31. Ward, D. G., Suggett, N., Cheng, Y., Wei, W., Johnson, H., Billingham, L. J., et al. (2006). Identification of serum biomarkers for colon cancer by proteomic analysis. British Journal of Cancer, 94, 1898-1905.
32. Wold, S., Sjostrom, M., & Eriksson, L. (2001). PLS-regression: a basic tool of chemometrics. Chemometrics and Intelligent Laboratory Systems, 58, 109-130.
33. Wolfbeis, O. S., & Leiner, M. (1985). Mapping of the total fluorescence of human-blood serum as a new method for its characterization. Analytica Chimica Acta, 167, 203-215.
34. Xu, X. R., Meng, J. W., Hou, S. G., Ma, H. P., & Wang, D. S. (1988). The characteristic fluorescence of the serum of cancer-patients. Journal of Luminescence, 40-1, 219-220.
35. Zhang, Xuewu, Li, Lin, Wei, Dong, Yap, Yeeleng, & Chen, Feng. (2007). Moving cancer diagnostics from bench to bedside. Trends in Biotechnology, 25, 166-173.
36. Zhao, Z., Xiao, Y., Elson, P., Tan, H., Plummer, S. J., Berk, M., et al. (2007). Plasma Lysophosphatidylcholine Levels: Potential Biomarkers for Colorectal Cancer. Journal of Clinical Oncology, 25, 2696-2701.